Ozi bụ isi
Aha ngwaahịa | Katalọgụ | Ụdị | Onye ọbịa/Isi iyi | Ojiji | Ngwa | COA |
HCV Core-NS3-NS5 fusion antigen | BMEHCV113 | Antigen | Ecoli | Were | ELISA, CLIA, WB | Budata |
HCV Core-NS3-NS5 fusion antigen | BMEHCV114 | Antigen | Ecoli | Conjugate | ELISA, CLIA, WB | Budata |
HCV Core-NS3-NS5 ngwakọta antigen-Bio | BMEHCVB01 | Antigen | Ecoli | Conjugate | ELISA, CLIA, WB | Budata |
Isi mmalite na-efe efe nke ịba ọcha n'anya C bụ nnukwu ụlọ ọgwụ na ndị ọrịa subclinical asymptomatic, ndị ọrịa na-adịghị ala ala na ndị na-ebu nje.Ọbara nke onye ọrịa n'ozuzu na-efe efe 12 ụbọchị tupu mmalite nke ọrịa ahụ, ma nwee ike ibu nje ahụ ihe karịrị afọ iri na abụọ.A na-ebutekarị HCV site na isi mmalite ọbara.Na mba ọzọ, 30-90% nke ịba ọcha n'anya mmịnye ọbara gachara bụ ịba ọcha n'anya C, na China, ịba ọcha n'anya C na-akpata 1/3 nke ịba ọcha n'anya mmịnye ọbara.Na mgbakwunye, enwere ike iji ụzọ ndị ọzọ, dị ka nnyefe nne na nwa kwụ ọtọ, kọntaktị ezinụlọ kwa ụbọchị na nnyefe mmekọahụ.
Mgbe etinyere plasma ma ọ bụ ngwaahịa ọbara nwere HCV ma ọ bụ HCV-RNA, ha na-akawanye njọ mgbe izu 6-7 nke oge ntinye.Ihe ngosi ụlọ ọgwụ bụ adịghị ike n'ozuzu, agụụ na-adịghị mma nke afọ, na ahụ erughị ala na mpaghara imeju.Otu ụzọ n'ụzọ atọ nke ndị ọrịa nwere jaundice, elu ALT, yana mgbochi mgbochi HCV dị mma.50% nke ndị ọrịa ịba ọcha n'anya C nwere ike ịmalite ịba ọcha n'anya na-adịghị ala ala, ọbụlagodi ụfọdụ ndị ọrịa ga-eduga na cirrhosis imeju na carcinoma hepatocellular.Ọkara nke fọdụrụ n'ime ndị ọrịa nwere oke onwe ha ma nwee ike ịgbake ozugbo.